Artesunate inhibits the migration and invasion of RA-SFs by targeting pyruvate dehydrogenase kinase 1, which in turn suppresses activation of v-akt murine thymoma viral oncogene homolog and phosphorylation of ribosomal S6 kinase 2 (RSK2). Here, RPS6KA3 is linked to rheumatoid arthritis.